Search

Your search keyword '"Gramegna, Andrea"' showing total 429 results

Search Constraints

Start Over You searched for: Author "Gramegna, Andrea" Remove constraint Author: "Gramegna, Andrea"
429 results on '"Gramegna, Andrea"'

Search Results

3. Covid-19 in cystic fibrosis patients compared to the general population: Severity and virus-host cell interactions

4. Maternal and fetal outcomes in multiparous women with Cystic Fibrosis

5. Standards for the care of people with cystic fibrosis (CF); Planning for a longer life

11. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

12. Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues

13. Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis

14. Standards for the care of people with cystic fibrosis; establishing and maintaining health

16. Clinical trials of pneumonia management assess heterogeneous outcomes and measurement instruments

17. Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosis

18. The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic

19. Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis

20. Antibiotics for lung disease and cancer

21. Standards of care and educational gaps in adult cystic fibrosis units: an ERS survey

22. A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

26. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

27. Diagnostic delay in bronchiectasis: an Italian perspective

28. Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review

29. Perceived burden of respiratory physiotherapy in people with cystic fibrosis taking elexacaftor–tezacaftor–ivacaftor combination: a 1-year observational study

31. Post-COVID-19 sequelae

33. Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders.

36. Clinical trials of pneumonia management assess heterogeneous outcomes and measurement instruments

37. Standards for the care of people with cystic fibrosis; establishing and maintaining health

39. Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis

40. Standards for the care of people with cystic fibrosis (CF)

42. An international perspective on hospitalized patients with viral community-acquired pneumonia

43. Lung volumes as possible factors explaining the heterogeneity in the response to elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease

45. The Successful Procedures Of weaning from Tracheostomy (SPOT) study: preliminary analysis of predictive factors for failure and validation of the QsQ score

48. Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes

49. COVID-19 multidisciplinary high dependency unit: the Milan model

Catalog

Books, media, physical & digital resources